Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:TSLA News 11 January 2026 - 16 January 2026

Tesla stock slips as U.S. safety probe on Full Self-Driving gets a new deadline

Tesla stock slips as U.S. safety probe on Full Self-Driving gets a new deadline

Tesla shares fell 0.2% to $438.57 early Friday after U.S. regulators extended the company’s deadline to respond to a federal probe into its Full Self-Driving system. The National Highway Traffic Safety Administration gave Tesla until Feb. 23 to address questions about alleged traffic-law violations. Investors await Tesla’s Jan. 28 earnings for updates on margins and software revenue.
16 January 2026
····
Tesla stock slips after Musk sets a deadline to end one-time Full Self-Driving sales

Tesla stock slips after Musk sets a deadline to end one-time Full Self-Driving sales

Tesla shares fell 0.2% to $438.45 after CEO Elon Musk said the company will end one-time purchases of its Full Self-Driving software, making subscriptions the only option from Feb. 14. The move comes as U.S. regulators continue to investigate safety issues linked to FSD. Tesla also agreed to mediation in a federal lawsuit alleging racial harassment at its Fremont plant, with talks expected in March or April.
15 January 2026
···
Ford stock ticks up as USMCA fight flares again — what investors watch next

Ford stock ticks up as USMCA fight flares again — what investors watch next

Ford shares rose 0.7% to $13.94 Thursday morning as CEO Jim Farley urged changes to the USMCA trade deal, calling it essential for North American manufacturing. The debate intensified after President Trump dismissed the deal during a visit to a Ford plant. Investors await Ford’s Feb. 10 earnings report for updated guidance. GM shares edged up 0.2%, Tesla gained 1%, and Stellantis slipped 1.2%.
15 January 2026
····
Tesla stock slides as Musk shifts Full Self-Driving to subscription-only, with earnings looming

Tesla stock slides as Musk shifts Full Self-Driving to subscription-only, with earnings looming

Tesla shares fell 1.8% to $439.20 Thursday morning after CEO Elon Musk said the Full Self-Driving feature will shift to a $99/month subscription model, ending the $8,000 purchase option after Feb. 14. The move comes as U.S. regulators investigate 2.88 million Teslas with FSD. Tesla also agreed to mediation in a federal lawsuit over alleged workplace harassment at its Fremont plant.
15 January 2026
····
Elon Musk net worth at $640B: he could buy every MLB, NBA, NFL and NHL team — and still have $103B left

Elon Musk net worth at $640B: he could buy every MLB, NBA, NFL and NHL team — and still have $103B left

Elon Musk’s net worth reached $640 billion as of Jan. 14, according to Bloomberg, with SpaceX listed as his largest asset. Benzinga estimates the combined value of all teams in the four major U.S. sports leagues at $536.8 billion. Musk’s fortune fluctuates with Tesla’s stock, court rulings, and private company valuations. Most of his wealth remains tied up in company stakes and stock options.
15 January 2026
·
NIO stock drops again as EU tariff rethink and China sales slowdown hit sentiment

NIO stock drops again as EU tariff rethink and China sales slowdown hit sentiment

Nio shares fell 1.6% to $4.61 in New York late Wednesday morning as the EU revived a “minimum price” tariff option for Chinese EVs. The China Association of Automobile Manufacturers forecast vehicle sales growth will slow to 1% in 2026. Nio said it will continue its European expansion despite new trade conditions. EU tariffs on Chinese EVs can reach up to 35.3%.
14 January 2026
······
Tesla stock dips as Musk kills the $8,000 Full Self-Driving buy option

Tesla stock dips as Musk kills the $8,000 Full Self-Driving buy option

Tesla shares fell 1.8% to $439.22 Wednesday after CEO Elon Musk said the company will end one-time purchases of its Full Self-Driving software, moving to subscriptions only after Feb. 14. The shift comes as U.S. regulators investigate safety concerns and Tesla faces a racism lawsuit mediation. Senior VP Xiaotong Zhu received a stock option grant for 520,021 shares. Fourth-quarter earnings are due Jan. 28.
14 January 2026
···
Tesla stock slips as Musk pulls $8,000 Full Self-Driving option, goes subscription-only

Tesla stock slips as Musk pulls $8,000 Full Self-Driving option, goes subscription-only

Tesla shares fell 0.4% to $447.20 after CEO Elon Musk said Full Self-Driving will shift to a subscription-only model on Feb. 14, ending the $8,000 upfront option. U.S. safety regulators continue to investigate 2.88 million Teslas with the system after dozens of crash reports. Investors await Tesla’s Jan. 28 earnings for updates on software revenue and regulatory issues.
14 January 2026
····
Tesla stock slips premarket after Musk says Full Self-Driving will be subscription-only from Feb. 14

Tesla stock slips premarket after Musk says Full Self-Driving will be subscription-only from Feb. 14

Tesla shares slipped 0.4% to $447.20 premarket after Elon Musk said the company will scrap its $8,000 Full Self-Driving one-time purchase, leaving only a monthly subscription. U.S. regulators continue to investigate Tesla’s driver-assist features. Separately, Tesla agreed to mediation in a federal lawsuit alleging racial harassment at its Fremont factory, with talks possible by spring.
14 January 2026
···
Tesla stock slips after SEC filing on top exec pay; Wall Street parses inflation

Tesla stock slips after SEC filing on top exec pay; Wall Street parses inflation

Tesla shares fell 0.4% to $447.31 Tuesday after a filing showed senior executive Tom Zhu received a large options grant priced at $435.80. Wolfe Research flagged rising costs and demand risks, projecting 2026 EPS below consensus. Investors await Tesla’s Jan. 28 earnings for updates on margins and software progress. The S&P 500 and Nasdaq also slipped 0.4% after the latest U.S. inflation data.
13 January 2026
··
Tesla stock ticks up in premarket as Wall Street weighs AI spend, lawsuit risk and demand

Tesla stock ticks up in premarket as Wall Street weighs AI spend, lawsuit risk and demand

Tesla shares rose 0.4% to $451 in premarket trading Tuesday as investors awaited the Jan. 28 earnings report. Wolfe Research warned increased AI spending could pressure 2026 profits but stayed “tactically constructive.” A class-action suit alleges defective door handles on 2014–2016 Model S cars. Tesla reported a 15.6% drop in Q4 deliveries, with full-year deliveries at 1.64 million.
13 January 2026
··
Tesla stock edges up after hours as robotaxi deadlines, CPI and earnings line up as next tests for TSLA

Tesla stock edges up after hours as robotaxi deadlines, CPI and earnings line up as next tests for TSLA

Tesla shares rose 0.9% to $448.90 in late Monday trading after a report outlined new 2026 plans including robotaxis and the “Cybercab.” More than 61 million shares traded as the S&P 500 and Dow hit record closes. Investors await Tuesday’s U.S. inflation data and Tesla’s Jan. 28 earnings report. Tesla’s annual sales recently fell for a second year, with China’s BYD now the top EV seller.
12 January 2026
···
Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla shares rose 0.7% to $448.09 Monday as investors awaited Tuesday’s U.S. inflation report and the company’s Jan. 28 earnings release. Roughly 23.7 million shares traded by late morning. Tesla reported over 434,000 vehicles produced and 418,000 delivered in Q4. Wall Street remains focused on Fed rate moves and Tesla’s progress on autonomy targets.
12 January 2026
····
Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla shares rose 2.1% to $445.01 in early New York trading Monday. The company delivered 418,227 vehicles in the fourth quarter, about 1% below analyst estimates, but set a record for energy storage deployments. Rivian, GM, and Ford all traded lower. Tesla is set to report earnings Jan. 28, with investors focused on robotaxi updates and profitability.
12 January 2026
·······
1 … 4 5 6 7 8 … 20

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Go toTop